Thesis Care Raises $45M Series A to Scale AI-Powered Clinical Operations
Thesis Care just walked into the room with $45M in fresh Series A capital and didn’t bother knocking. When a company renames itself from Trovo Health to Thesis Care the same day it raises, that’s not branding, that’s a statement. This is the argument, fully formed.
Credit where it’s due. Niren Gandra, M.D., CEO & Co-Founder, and Aditya Pandyaram, Co-Founder, didn’t just build another healthtech layer hoping clinicians would click around. They built something that does the work. AI agents paired with actual clinicians, executing clinical operations and care management end to end, no extra logins, no workflow gymnastics, no polite request for already burned out staff to “just try one more tool.” That detail matters more than the headline.
Oak HC/FT doubled down and led the round like they’ve seen this movie before and already know the ending. CRV and Black Opal Ventures stepped in with them, alongside a bench of healthcare operators who’ve lived the problem, not just modeled it. That kind of investor mix doesn’t chase noise. It backs inevitability.
The company has been moving quietly but not slowly. From design partnerships to real commercial traction in a year, working with names like US Heart & Vascular, Essen Health Care, Springfield Clinic, Unio Health Partners, and Allied Digestive Health. Not vanity logos. Operational proving grounds where complexity isn’t a bug, it’s the job.
And the product philosophy is where things get surgical. Thesis Care doesn’t ask systems to adapt to software. It adapts to the system, completes the task, and hands back the result. That’s a different kind of AI conversation. Less “look what we built,” more “look what’s already done.”
The takeaway for anyone building right now is simple, but not easy. Distribution follows usefulness. Usefulness comes from understanding where the real work lives, not where the demo looks clean. Niren Gandra, M.D. and Aditya Pandyaram brought operator DNA from Cedar, saw where care teams were breaking, and built something that absorbs pressure instead of adding to it.
$60M total funding in under 2 years tells you the market agrees. Not because AI is trendy, but because capacity in healthcare is finite and demand isn’t asking for permission to grow. Some companies sell software. Some sell time back. Thesis Care is quietly positioning itself to sell something even more valuable: completed work in a system that’s drowning in it. And if you listen closely, that’s not hype talking. That’s relief.
